Status:
RECRUITING
Effectiveness of Virtual Reality Vision Therapy - VERVE
Lead Sponsor:
OculoMotor Technologies
Collaborating Sponsors:
New Jersey Institute of Technology
Salus University
Conditions:
Convergence Insufficiency
Eligibility:
All Genders
9-35 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this research study is to see how well the treatment of a participant's eye coordination and/or focusing problems improves eye muscle responses and symptoms of eyestrain. We will use an...
Eligibility Criteria
Inclusion
- Age 9 years and older
- CISS score ≥ 16
- Best-corrected distance visual acuity of 20/25 or better in each eye
- Random dot stereopsis appreciation of 500 seconds of arc or better
- Parent or subject understands the protocol and is willing to enroll in the study
Exclusion
- Constant strabismus at distance or near
- Vertical heterophoria ≥ 2 ∆ at distance or near
- ≥ 2 line interocular difference in best-corrected visual acuity
- Near point of accommodation \> 20 cm in either eye as measured by push-up method
- Manifest or latent nystagmus
- Non-strabismic binocular vision and accommodative disorders associated with known disease of the brain
- Diseases known to affect accommodation, vergence, or ocular motility such as multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, Parkinson disease
- Any ocular or systemic medication known to affect accommodation or vergence such as anti-anxiety agents (e.g., Librium or Valium), anti-arrhythmic agents (e.g., Cifenline, Cibenzoline), anti-cholinergics, bladder spasmolytic drugs (e.g., Propiverine), hydroxychloroquine, chloroquine, phenothiazines (e.g., Compazine, Mellaril, Thorazine), tricyclic antidepressants (e.g., Elavil, Nortriptyline, Tofranil)
- Inability to comprehend and/or perform any study-related test or procedure
Key Trial Info
Start Date :
October 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04691427
Start Date
October 14 2021
End Date
September 1 2024
Last Update
April 16 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
OculoMotor Technologies
Newark, New Jersey, United States, 07103
2
The Eye Institute at Salus University
Philadelphia, Pennsylvania, United States, 19141